FASIHA KANWAL to Cost-Benefit Analysis
This is a "connection" page, showing publications FASIHA KANWAL has written about Cost-Benefit Analysis.
Connection Strength
1.290
-
Cost-effectiveness and Decision Analysis in Clinical Gastroenterology and Hepatology: From Evidence to Informed Decision Making. Clin Gastroenterol Hepatol. 2018 04; 16(4):459-461.
Score: 0.496
-
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Netw Open. 2019 05 03; 2(5):e193613.
Score: 0.137
-
Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2019 03; 17(4):739-747.e8.
Score: 0.130
-
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10.
Score: 0.120
-
Why We Should Be Willing to Pay for Hepatitis C Treatment. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1711-3.
Score: 0.104
-
Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis. Am J Gastroenterol. 2006 Sep; 101(9):2076-89.
Score: 0.057
-
Impact of chronic viral hepatitis on health-related quality of life in HIV: results from a nationally representative sample. Am J Gastroenterol. 2005 Sep; 100(9):1984-94.
Score: 0.053
-
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med. 2005 May 17; 142(10):821-31.
Score: 0.052
-
The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. Gastroenterology. 2004 Aug; 127(2):403-11.
Score: 0.049
-
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication. J Hepatol. 2022 07; 77(1):55-62.
Score: 0.041
-
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015 Mar 17; 162(6):397-406.
Score: 0.026
-
The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):988-997.
Score: 0.014
-
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003 Jul; 9(7):672-81.
Score: 0.011